Cancer vaccine shows promise for patients with stage III and IV kidney cancer

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup